GLUCOTROL XL 5mg modified release tablets medication leaflet

A10BB07 glipizide • Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sulfonylureas

Glipizide is an antidiabetic medication from the sulfonylurea class, used to control blood sugar levels in patients with type 2 diabetes. It works by stimulating the pancreas to produce more insulin, thereby helping to lower blood sugar levels.

It is recommended as part of a treatment plan that includes a balanced diet, regular physical activity, and blood sugar monitoring. Glipizide is effective in reducing the risk of diabetes-related complications, such as damage to small blood vessels (retinopathy, nephropathy).

Side effects may include hypoglycemia (excessive drop in blood sugar), nausea, dizziness, weight gain, or allergic reactions. It is important for patients to follow the prescribed dosage and watch for signs of hypoglycemia, such as shaking, sweating, or confusion.

General data about GLUCOTROL XL 5mg

Substance: glipizide

Date of last drug list: 01-12-2018

Commercial code: W65038001

Concentration: 5mg

Pharmaceutical form: modified release tablets

Quantity: 30

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: FAREVA AMBOISE - FRANTA

Holder: PFIZER EUROPE MA EEIG - BELGIA

Number: 12729/2019/01

Shelf life: 3 years

Pharmaceutical forms available for glipizide

Concentrations available for glipizide

10mg, 5mg